Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pierelli

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|January 1, 1997
Generation of multinuclear tartrate-resistant acid phosphatase positive osteoclasts in liquid culture of purified human peripheral blood CD34+ progenitorsL Pierelli, G Scambia, G d'Onofrio, et al.
Experimental Hematology|March 25, 1999
Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15L Pierelli, G Scambia, G Bonanno, et al.
Journal of Clinical Apheresis|January 1, 1997
Evaluation of a new protocol for peripheral blood stem cell collection with the Fresenius AS 104 cell separatorG Menichella, M Lai, L Pierelli, et al.
British Journal of Haematology|September 30, 1998
Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haemopoietic progenitorsL Pierelli, G Scambia, A Fattorossi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 18, 2007
Expression of CD133-1 and CD133-2 in ovarian cancerG Ferrandina, G Bonanno, L Pierelli, et al.
British Journal of Haematology|September 21, 2000
High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitorsM Marone, L Pierelli, S Mozzetti, et al.
Anticancer Research|June 9, 2001
Docetaxel and epirubicin plus G-CSF as mobilizing treatment to support high-dose chemotherapy in breast cancerL De Rosa, M Lalle, A Perillo, et al.
Transfusion|January 5, 2002
The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSFL Pierelli, A Perillo, G Ferrandina, et al.
British Journal of Cancer|January 1, 1997
High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administrationP Benedetti Panici, L Pierelli, G Scambia, et al.
Bone Marrow Transplantation|October 31, 2002
Administration of low-dose interleukin-2 plus G-CSF/EPO early after autologous PBSC transplantation: effects on immune recovery and NK activity in a prospective study in women with breast and ovarian cancerA Perillo, L Pierelli, A Battaglia, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|January 1, 1997
Generation of multinuclear tartrate-resistant acid phosphatase positive osteoclasts in liquid culture of purified human peripheral blood CD34+ progenitorsL Pierelli, G Scambia, G d'Onofrio, et al.
Experimental Hematology|March 25, 1999
Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15L Pierelli, G Scambia, G Bonanno, et al.
Journal of Clinical Apheresis|January 1, 1997
Evaluation of a new protocol for peripheral blood stem cell collection with the Fresenius AS 104 cell separatorG Menichella, M Lai, L Pierelli, et al.
British Journal of Haematology|September 30, 1998
Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haemopoietic progenitorsL Pierelli, G Scambia, A Fattorossi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 18, 2007
Expression of CD133-1 and CD133-2 in ovarian cancerG Ferrandina, G Bonanno, L Pierelli, et al.
British Journal of Haematology|September 21, 2000
High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitorsM Marone, L Pierelli, S Mozzetti, et al.
Anticancer Research|June 9, 2001
Docetaxel and epirubicin plus G-CSF as mobilizing treatment to support high-dose chemotherapy in breast cancerL De Rosa, M Lalle, A Perillo, et al.
Transfusion|January 5, 2002
The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSFL Pierelli, A Perillo, G Ferrandina, et al.
British Journal of Cancer|January 1, 1997
High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administrationP Benedetti Panici, L Pierelli, G Scambia, et al.
Bone Marrow Transplantation|October 31, 2002
Administration of low-dose interleukin-2 plus G-CSF/EPO early after autologous PBSC transplantation: effects on immune recovery and NK activity in a prospective study in women with breast and ovarian cancerA Perillo, L Pierelli, A Battaglia, et al.
Pageof 12